Recent Finacing
Recent Raise
Autoimmunity BioSolutions is a biotechnology company developing a personalized, genetically guided immuno-corrective therapy that normalizes elevated soluble IL7 receptor (sIL7R) in autoimmune patients.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Autoimmunity BioSolutions.
